Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zambon

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 18, 2014
Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season resultsN Andrews, J McMenamin, H Durnall, et al.
Epidemiology and Infection|August 16, 2012
Microbiological aspects of public health planning and preparedness for the 2012 Olympic GamesJ Moran-Gilad, M Chand, C Brown, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2013
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protectionR G Pebody, N Andrews, J McMenamin, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancyR L Puleston, G Bugg, K Hoschler, et al.
Clinical and Experimental Immunology|November 1, 2019
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in childrenP J Turner, A F Abdulla, M E Cole, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apartK G Nicholson, K R Abrams, S Batham, et al.
Journal of Infection and Public Health|September 22, 2022
Nosocomial acquisition of influenza is associated with significant morbidity and mortality: Results of a prospective observational studyL B Snell, J P Vink, N Q Verlander, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 14, 2015
Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season resultsR G Pebody, F Warburton, J Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Self-sampling for community respiratory illness: a new tool for national virological surveillanceA J Elliot, A Bermingham, A Charlett, et al.
Epidemiology and Infection|June 14, 2012
Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United KingdomR G Pebody, N Andrews, D M Fleming, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 18, 2014
Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season resultsN Andrews, J McMenamin, H Durnall, et al.
Epidemiology and Infection|August 16, 2012
Microbiological aspects of public health planning and preparedness for the 2012 Olympic GamesJ Moran-Gilad, M Chand, C Brown, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2013
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protectionR G Pebody, N Andrews, J McMenamin, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancyR L Puleston, G Bugg, K Hoschler, et al.
Clinical and Experimental Immunology|November 1, 2019
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in childrenP J Turner, A F Abdulla, M E Cole, et al.
Health Technology Assessment (Winchester, England)|January 7, 2011
A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apartK G Nicholson, K R Abrams, S Batham, et al.
Journal of Infection and Public Health|September 22, 2022
Nosocomial acquisition of influenza is associated with significant morbidity and mortality: Results of a prospective observational studyL B Snell, J P Vink, N Q Verlander, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 14, 2015
Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season resultsR G Pebody, F Warburton, J Ellis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 20, 2015
Self-sampling for community respiratory illness: a new tool for national virological surveillanceA J Elliot, A Bermingham, A Charlett, et al.
Epidemiology and Infection|June 14, 2012
Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United KingdomR G Pebody, N Andrews, D M Fleming, et al.
Pageof 12